Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies

The evaluation of pharmaceutical innovation and therapeutic value is an increasingly complex exercise for which different approaches are adopted at the national level, despite the need for standardisation of processes and harmonisation of public health decisions. The objective of our analysis was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xoxi, Entela, Di Bidino, Rossella, Leone, Serena, Aiello, Andrea, Prada, Mariangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483157/
https://www.ncbi.nlm.nih.gov/pubmed/36134249
http://dx.doi.org/10.3389/fmedt.2022.917151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483157/
https://www.ncbi.nlm.nih.gov/pubmed/36134249
http://dx.doi.org/10.3389/fmedt.2022.917151

Ejemplares similares